Getting your player ready...
LONDON — Doctors who gave diabetics a drug originally intended to lower patients’ cholesterol found it reduced their risk of so-called minor amputation by 36 percent, a new analysis of research says.
Researchers in Australia, Finland and New Zealand studied almost 10,000 patients ages 50 to 75 with type 2 diabetes, the kind linked to obesity. About half of the patients were given fenofibrate, a drug available generically and sold as Antara, Fenoglide, Lipofen and others. The other half got fake pills.
A new look at the data found patients on the drug had a 36 percent lower risk of a first amputation.
